SA Tuberculosis Vaccine Initiative

Search

November 2018

15 November 2018 LATEST RESEARCH: Commentary WHO Preferred Product Preferences for TB Vaccines - 15 Nov 2018 - 11:30
15 November 2018 LATEST RESEARCH: Commentary WHO Preferred Product Preferences for TB Vaccines - 15 Nov 2018 - 11:30
13 November 2018 RESEARCH Can we predict tuberculosis cure? What tools are available? - 13 Nov 2018 - 12:45

October 2018

LIVE PRESS CONFERENCE: Union World Conference on Lung Health : M72 Vaccine study primary results presented - 28 Oct 2018 - 09:30
23 October 2018 SATVI at the Union Conference on Lung Health - 23 Oct 2018 - 12:00

September 2018

25 September 2018 Research Published: Candidate tuberculosis (TB) vaccine can prevent active pulmonary TB in HIV-negative adults in phase II study - 25 Sep 2018 - 17:45
7 September 2018 Latest Research: PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis - 7 Sep 2018 - 16:00
Latest Research: Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination - 5 Sep 2018 - 11:45

August 2018

Coming Event: Kick TB Poster and Writing Exhibit - 27 Aug 2018 - 10:30
22 August 2018 Research Published: Infectious Diseases: Natural killers associated with latent Tuberculosis - 22 Aug 2018 - 22:00
20 August 2018 Research Published: Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes - 21 Aug 2018 - 11:15
17 August 2018 Research: Prospects for a vaccine to prevent HIV related Tuberculosis - 20 Aug 2018 - 15:45

July 2018

Celebrating the legacy of Nelson Mandela - 19 Jul 2018 - 12:45
Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines. - 12 Jul 2018 - 08:15

June 2018

Vaccine Honours students - 27 Jun 2018 - 21:00

May 2018

Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts - 29 May 2018 - 14:15

April 2018

11 April 2018 SATVI 2017 Annual Report Now available - 11 Apr 2018 - 13:00
Latest Research: Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis - 9 Apr 2018 - 14:45
Postdoctoral Vacancy: TB Vaccine Trial Immunology - 6 Apr 2018 - 15:00

March 2018

Latest Research: Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial - 24 Mar 2018 - 09:45
23 March 2018 TB under the Spotlight Science Engagement launched - 22 Mar 2018 - 21:45
20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands - 19 Mar 2018 - 19:30
20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands - 19 Mar 2018 - 12:45
19 March 2018 Launch of TB under Spotlight Science Engagement - 19 Mar 2018 - 08:15

February 2018

19 February 2018 Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines - 19 Feb 2018 - 20:00

November 2017

Vacancy Research Pharmacist - 21 Nov 2017 - 12:15
New Gobal commitment to end TB - 20 Nov 2017 - 08:30
Progression from infection to Pulmonary Tuberculosis follows distinct timeline - 17 Nov 2017 - 08:15
4 November 2017 SATVI offers bursary to cover Registration fee to cover SciMathUS program - 14 Nov 2017 - 09:00
9 November 2017 Research Published: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development - 9 Nov 2017 - 14:15
25 October 2017 Research Published Polyfunctional CD4+TCells as targets for vaccination - 6 Nov 2017 - 14:45

October 2017

5 October 2017 RESEARCH: Safety and Immunogenicity Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 Randomized Controlled Trial - 5 Oct 2017 - 11:30
3 October 2017 Research: Host blood signatures RNA predict the outcome of tuberculosis treatment - 3 Oct 2017 - 10:30

September 2017

21 September 2017 Vacancy Research Officer: Systems Immunology - 21 Sep 2017 - 18:15
14 September 2017 Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population - 15 Sep 2017 - 09:00
8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis - 8 Sep 2017 - 08:00
7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire - 7 Sep 2017 - 17:15
6 september 2017 Research Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice - 6 Sep 2017 - 20:15
6 September 2017 Research Published: Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice - 6 Sep 2017 - 20:15
6 September 2017 SATVI marks 3000th patient screened in CORTIS HR study. - 6 Sep 2017 - 19:00

Pages

Contact us

General Enquiries:

Tel +27 21 406 6791

Worcester Field Site Office

Tel+ 27 23 346 5400

Email: Information

SATVI Cape Town Offices:

Wernher and Beit South Building, Room S2.01, University of Cape Town , Anzio Road, OBSERVATORY, 7925

Tel: +27 21 406 6791

Fax:+27 21 406 6081

Email: Director

SATVI Worcester Site Office:

SATVI Project Office, University of Cape Town, Brewelskloof Hospital,  Haarlem Street, WORCESTER, 6850.

Tel: +27 23 346 5400

Fax: +27 23 346  5406

Email: Field Site Manager

GPS coordinates -33.620455, 19.458576

Map to Worcester Field Office